Fmoc-val-cit-pab

CAS : 159858-22-7

Ref. 3D-FF176695

Informations sur le produit

• Nom: Fmoc-val-cit-pab
• Synonymes: N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide, L-Ornithinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-

Description

Fmoc-Val-Cit-Pab is a modulator that targets the HER2 receptor. The antibody is designed to bind to a specific region of the HER2 receptor, which may be involved in initiating the cancerous process. This antibody has shown promising results in preclinical studies and clinical trials for breast cancer with HER2 overexpression. Fmoc-Val-Cit-Pab can be used as an immunotherapy for patients with metastatic her2-positive cancers. It also has regulatory properties and does not react with normal cells, making it safer than other monoclonal antibodies.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 601.69 g/mol
• Formule: C₃₃H₃₉N₅O₆
• Degré de pureté: Min. 95%